|
OncoMed Pharmaceuticals, Inc. [OMED] to Ring The NASDAQ Stock Market …
NASDAQ OncoMed Pharmaceuticals, Inc. [OMED], a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, will visit the NASDAQ MarketSite in Times Square. In honor of the occasion, Paul J. Hastings, … |